RA (n = 50) | NHS (n = 30) | P | |
---|---|---|---|
Demographics | |||
Age (mean ± SD, yrs) | 58.4 + 13.1 | 56.7 + 16.7 | ns |
Sex (n, % female) | 34 (68.0) | 20 (66.6) | ns |
Inflammatory markers | |||
ESR (mm/h, mean ± IQR) | 22.9 + 17.6 | 10.6 + 9.3 | 0.000 |
CRP (mg/L ± IQR) | 5.4 + 5.7 | 2.9 + 1.7 | 0.000 |
RA disease characteristics | |||
Disease duration (months, mean ± SD) | 127 + 97.6 | n.a. | n.a. |
DAS 28 (mean ± SD) | 4.0 + 1.5 | n.a. | n.a. |
ACPA positivity (n, %) | 35 (70) | 0 (0) | 0.000 |
RF positivity (n, %) | 34 (68) | 0 (0) | 0.000 |
Anti-CarP positivity (n, %) | 19 (38) | 0 (0) | 0.000 |
Traditional Cardiovascular risk factors | |||
Smoking, current (n, %) | 15 (30) | 5 (16.6) | 0.002 |
Systolic blood pressure (mmHg, mean ± SD) | 135.5 + 19.5 | 135.06 + 19.01 | ns |
Diastolic blood pressure (mmHg, mean ± SD) | 84.5 + 10.8 | 80.5 + 8.91 | ns |
Total Cholesterol (mg/dl, mean ± SD) | 188 + 37.6 | 186 + 34.6 | ns |
HDL cholesterol (mg/dl, mean ± SD) | 60.06 + 14.25 | 40.5 + 6.6 | 0.001 |
LDL cholesterol (mg/dl, mean ± SD) | 117 + 35.5 | 114 + 32.3 | 0.02 |
Triglycerides (mg/dl, mean ± SD) | 93.2 + 35.9 | 93.1 + 35.01 | ns |
Body Mass Index (kg/m2, mean ± SD) | 24.8 + 4.19 | 25.4 + 4.54 | ns |